TGF beta receptor

Multi tool use
transforming growth factor beta, receptor type I (activin A receptor type II-like kinase, 53kDa) |
Identifiers |
Symbol |
TGFBR1 |
Alt. symbols |
ALK5 |
Entrez |
7046 |
HUGO |
11772 |
OMIM |
190181 |
RefSeq |
NM_004612 |
UniProt |
P36897 |
Other data |
Locus |
Chr. 9 q22
|
transforming growth factor beta, receptor type II (70/80kDa) |
Identifiers |
Symbol |
TGFBR2 |
Alt. symbols |
MFS2 |
Entrez |
7048 |
HUGO |
11773 |
OMIM |
190182 |
RefSeq |
NM_001024847 |
UniProt |
P37173 |
Other data |
Locus |
Chr. 3 p22
|
transforming growth factor beta, receptor type III |
Identifiers |
Symbol |
TGFBR3 |
Alt. symbols |
β-Glycan |
Entrez |
7049 |
HUGO |
11774 |
OMIM |
600742 |
RefSeq |
NM_003243 |
UniProt |
Q03167 |
Other data |
Locus |
Chr. 1 p33-p32
|
Transforming growth factor beta (TGFβ) receptors are single pass serine/threonine kinase receptors that belong to TGFβ receptor family. They exist in several different isoforms that can be homo- or heterodimeric.[1] The number of characterized ligands in the TGFβ superfamily far exceeds the number of known receptors, suggesting the promiscuity that exists between the ligand and receptor interactions.
TGFβ is a growth factor and cytokine involved in paracrine signalling and can be found in many different tissue types, including brain, heart, kidney, liver, bone, and testes. Over-expression of TGFβ can induce renal fibrosis, causing kidney disease, as well as diabetes, and ultimately end-stage renal disease. Recent developments have found that, using certain types of protein antagonists against TGFβ receptors, can halt and in some cases reverse the effects of renal fibrosis.
Three TGFβ superfamily receptors specific for TGFβ, the TGFβ receptors, can be distinguished by their structural and functional properties. TGFβR1 (ALK5) and TGFβR2 have similar ligand-binding affinities and can be distinguished from each other only by peptide mapping. Both TGFβR1 and TGFβR2 have a high affinity for TGFβ1 and low affinity for TGFβ2. TGFβR3 (β-glycan) has a high affinity for both homodimeric TGFβ1 and TGFβ2 and in addition the heterodimer TGF-β1.2.[2] The TGFβ receptors also bind TGFβ3.
See also
- TGFβ superfamily receptor
- TGFβ signaling pathway
- TGFβ superfamily
References
^ Doré JJ, Edens M, Garamszegi N, Leof EB (November 1998). "Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells". The Journal of Biological Chemistry. 273 (48): 31770–7. doi:10.1074/jbc.273.48.31770. PMID 9822641..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"""""""'""'"}.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em} (free full text)
^ Cheifetz S, Andres JL, Massagué J (November 1988). "The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor". The Journal of Biological Chemistry. 263 (32): 16984–91. PMID 2903157.
External links
TGF-beta+Receptors at the US National Library of Medicine Medical Subject Headings (MeSH)
Cell signaling: TGFβ signaling pathway
|
TGF beta superfamily of ligands |
TGF beta family |
|
Bone morphogenetic proteins |
- BMP2
- BMP3
- BMP4
- BMP5
- BMP6
- BMP7
- BMP8a
- BMP8b
- BMP10
- BMP15
|
Growth differentiation factors |
- GDF1
- GDF2
- GDF3
- GDF5
- GDF6
- GDF7
- Myostatin/GDF8
- GDF9
- GDF10
- GDF11
- GDF15
|
Other |
- Activin and inhibin
- Anti-müllerian hormone
- Nodal
|
|
TGF beta receptors (Activin, BMP) |
TGFBR1: |
Activin type 1 receptors
- ACVRL1
BMPR1
|
TGFBR2: |
Activin type 2 receptors
- AMHR2
- BMPR2
|
TGFBR3: |
|
|
Transducers/SMAD
|
R-SMAD (SMAD1
- SMAD2
- SMAD3
- SMAD5
SMAD9)
I-SMAD (SMAD6
SMAD7)
- SMAD4
|
Ligand inhibitors |
- Cerberus
- Chordin
- Decorin
- Follistatin
- Gremlin
- Lefty
- LTBP1
- Noggin
- PARN
- THBS1
|
Coreceptors |
|
Other |
|
Receptors: growth factor receptors
|
Type I cytokine receptor |
Nerve growth factors: Ciliary neurotrophic factor
- Erythropoietin
|
Receptor protein serine/threonine kinase |
TGF pathway: TGF-beta
Activin
Bone morphogenetic protein
|
Receptor tyrosine kinase |
|
Nerve growth factors: high affinity Trk
|
|
Somatomedin
- Insulin-like growth factor 1
|
ErbB/Epidermal growth factor
|
|
|
Tumor necrosis factor receptor |
Nerve growth factors: Low affinity/p75
|
Ig superfamily |
Platelet-derived growth factor
- Stem cell factor
|
Other/ungrouped |
Somatomedin
- Insulin-like growth factor 2
|
Cytokine receptors
|
Chemokine receptor (GPCRs) |
CC |
CCR1 / CCRL1
- CCR2
- CCRL2
- CCR3
- CCR4
- CCR5
- CCR6
- CCR7
- CCR8
- CCR9
- CCR10
|
CXC |
IL-8
- CXCR3
- CXCR4
- CXCR5
- CXCR6
- CXCR7
|
Other |
|
|
TNF receptor |
1-10 |
TNFR1 (TNFRSF1A)
TNFR2 (TNFRSF1B)
LTBR (TNFRSF3)
CD134 (TNFRSF4)
CD40 (TNFRSF5)
Fas receptor (TNFRSF6)
DcR3 (TNFRSF6B)
CD27 (TNFRSF7)
CD30 (TNFRSF8)
CD137 (TNFRSF9)
|
11-20 |
DR4 (TNFRSF10A)
DR5 (TNFRSF10B)
DcR1 (TNFRSF10C)
DcR2 (TNFRSF10D)
RANK (TNFRSF11A)
Osteoprotegerin (TNFRSF11B)
TweakR (TNFRSF12A)
TACI (TNFRSF13B)
BAFFR (TNFRSF13C)
HVEM (TNFRSF14)
NGFR (TNFRSF16)
BCMA (TNFRSF17)
GITR (TNFRSF18)
TAJ/TROY (TNFRSF19)
|
21-27 |
DR6 (TNFRSF21)
DR3 (TNFRSF25)
EDA2R (TNFRSF27)
|
|
JAK-STAT |
Type I |
γ-chain |
Interleukin receptors
IL2R / IL2RA/IL2RB / IL15R
IL4R / IL13R / IL13RA1 / IL13RA2
IL7R / IL7RA
- IL9R
- IL21R
|
β-chain |
Interleukin receptors
IL3R / IL3RA
IL5R / IL5RA
- GM-CSF
|
gp130 |
Interleukin receptors
- IL6RA
11/IL11RA
27/IL27RA
- OSMR
- LIFR
- CNTFR
|
IL12RB1 |
Interleukin receptors
IL12R/IL12RB1/IL12RB2
- IL23R23
|
Other |
hormone receptor: GH
- prolactin
|
|
Type II |
Interleukin receptors
IL10R / IL10RA / IL10RB / IL22R / IL22RA1 / IL22RA2
IL20R / IL20RA / IL20RB
- IL28R
Interferon receptors
-α/β / IFNAR1/IFNAR2
-γ/IFNGR1 / IFNGR2
|
|
Ig superfamily |
- CSF1
- KIT
IL1
IL18R / IL18R1
|
IL 17 family |
IL17
- IL17RA
- IL17RB
- IL17RC
- IL17RD
- IL17RE
|
S/T |
|
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
|
Polo kinase (EC 2.7.11.21) |
|
Cyclin-dependent kinase (EC 2.7.11.22) |
- CDK1
- CDK2
- CDKL2
- CDK3
- CDK4
- CDK5
- CDKL5
- CDK6
- CDK7
- CDK8
- CDK9
- CDK10
- CDK12
- CDC2L5
- PCTK1
- PCTK2
- PCTK3
- PFTK1
- CDC2L1
|
(RNA-polymerase)-subunit kinase (EC 2.7.11.23) |
- RPS6KA5
- RPS6KA4
- P70S6 kinase
- P70-S6 Kinase 1
- RPS6KB2
- RPS6KA2
- RPS6KA3
- RPS6KA1
- RPS6KC1
|
Mitogen-activated protein kinase (EC 2.7.11.24) |
Extracellular signal-regulated
- MAPK1
- MAPK3
- MAPK4
- MAPK6
- MAPK7
- MAPK12
- MAPK15
C-Jun N-terminal
P38 mitogen-activated protein
|
MAP3K (EC 2.7.11.25) |
MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
RAFs
MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
- MAP3K14
|
Tau-protein kinase (EC 2.7.11.26) |
|
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27) |
|
Tropomyosin kinase (EC 2.7.11.28) |
|
Low-density-lipoprotein receptor kinase (EC 2.7.11.29) |
|
Receptor protein serine/threonine kinase (EC 2.7.11.30) |
Bone morphogenetic protein receptors
- BMPR1
- BMPR1A
- BMPR1B
- BMPR2
- ACVR1
- ACVR1B
- ACVR1C
- ACVR2A
- ACVR2B
- ACVRL1
- Anti-Müllerian hormone receptor
|
|
|
Dual-specificity kinases (EC 2.7.12)
|
MAP2K |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
|
|
TGFβ receptor superfamily modulators
|
Type I |
ALK1 (ACVRL1) |
Agonists: Activin (A, B, AB)
- Avotermin
BMP (10)
- Cetermin
GDF (2 (BMP9))
TGFβ (1, 2, 3)
Antibodies: Ascrinvacumab
Kinase inhibitors: K-02288
- ML-347 (LDN-193719, VU0469381)
Decoy receptors: Dalantercept
Other inhibitors: Disitertide
|
ALK2 (ACVR1A) |
Agonists: Activin (A, B, AB)
- AMH (MIS)
- Avotermin
BMP (5, 6, 7, 8A, 8B)
- Eptotermin alfa
TGFβ (1, 2, 3)
Kinase inhibitors: DMH-1
- DMH-2
- Dorsomorphin (BML-275)
- K-02288
- ML-347 (LDN-193719, VU0469381)
|
ALK3 (BMPR1A) |
Agonists: AMH (MIS)
BMP (2, 4, 5, 6, 7, 8A, 8B)
- Dibotermin alfa
- Eptotermin alfa
Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
ALK4 (ACVR1B) |
Agonists: Activin (A, B, AB)
GDF (1, 3, 11 (BMP11))
- Myostatin (GDF8)
- Nodal
Antagonists: Inhibin (A, B)
Lefty (1, 2)
Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
ALK5 (TGFβR1) |
Agonists: Avotermin
GDF (10 (BMP3B), 11 (BMP11))
TGFβ (1, 2, 3)
Antibodies: Fresolimumab
- Lerdelimumab
- Metelimumab
Kinase inhibitors: A 83-01
- D-4476
- GW-788388
- LY-364947
- LY-2109761
- Galunisertib (LY-2157299)
- R-268712
- RepSox (E-616452, SJN-2511)
- SB-431542
- SB-505124
- SB-525334
- SD-208
|
ALK6 (BMPR1B) |
Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
- Radotermin
Kinase inhibitors: DMH-2
- Dorsomorphin (BML-275)
- K-02288
|
ALK7 (ACVR1C) |
Agonists: GDF (1, 3, 11 (BMP11))
- Nodal
Antagonists: Lefty (1, 2)
Kinase inhibitors: A 83-01
- SB-431542
- SB-505124
|
|
Type II |
TGFβR2 |
Agonists: Avotermin
GDF (10 (BMP3B))
TGFβ (1, 2, 3)
Antibodies: Fresolimumab
- Lerdelimumab
- Metelimumab
Kinase inhibitors: DMH-2
- LY-364947
|
BMPR2 |
Agonists: BMP (2, 4, 6, 7, 10)
- Dibotermin alfa
- Eptotermin alfa
GDF (2 (BMP9), 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Radotermin
Antagonists: Inhibin (A, B)
|
ACVR2A (ACVR2) |
Agonists: Activin (A, B, AB)
BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
- Dibotermin alfa
- Eptotermin alfa
GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
- Myostatin (GDF8)
- Nodal
- Radotermin
Antagonists: Inhibin (A, B)
Lefty (1, 2)
Decoy receptors: Sotatercept
|
ACVR2B |
Agonists: Activin (A, B, AB)
BMP (2, 4, 6, 7)
- Dibotermin alfa
- Eptotermin alfa
GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
- Myostatin (GDF8)
- Nodal
- Osteogenin (BMP3, BMP3A)
- Radotermin
Antagonists: Inhibin (A, B)
Lefty (1, 2)
Decoy receptors: Ramatercept
|
AMHR2 (AMHR) |
|
|
Type III |
TGFβR3 (β-glycan) |
Ligands: Avotermin
Inhibin (A, B)
TGFβ (1, 2, 3)
|
|
Unsorted |
Endogenous antagonists/inhibitors: BAMBI
- Cerberus (CER1)
- Chordin
- DAN (PARN)
- Decorin
- Follistatin
- Gremlin (Drm)
- LTBP1
- Noggin
- TGIF
- Thrombospondin 1 (THBS1)
- Tomoregulin 1
Antibodies: Stamulumab (against myostatin)
TRC105 (against endoglin)
|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Growth factor receptor modulators
- Cytokine receptor modulators
|
cefSKgJ2P UNqnsLL,kry,jLXHprw N8FPspEjeEiowNAL7SnHT0uTDKGW,kBh UX eybHBCHtqbB59v0,3TkzfH1GLHgM7SuO0YD
Popular posts from this blog
"Italian restaurant" redirects here. For the television series, see Italian Restaurant. Some typical Italian gastronomic products in a window display in Imola Pizza is one of the world's most popular foods and a common fast food item Part of a series on the Culture of Italy History People Languages Traditions Mythology and folklore Mythology folklore Cuisine Festivals Religion Art Literature Music and performing arts Music Media Television Cinema Sport Monuments World Heritage Sites Symbols Flag Coat of arms Italy portal v t e Italian cuisine History Ancient Roman cuisine Medieval cuisine Early modern cuisine Contemporary cuisine Regional cuisines Apulian cuisine Lombard cuisine Neapolitan cuisine Roman cuisine Sicilian cuisine Venetian cuisine Cuisine of Abruzzo Cuisine of Sardinia Lists Chefs Dishes Pas...
Part of a series on Bulgarians .mw-parser-output .nobold{font-weight:normal} българи Culture Literature Music Art Cinema Names Cuisine Dances Costume Sport Public holidays in Bulgaria By country Albania Australia Canada Czechoslovakia Greece New Zealand Romania Serbia South America Turkey Ukraine United States Bulgarian citizens France Germany Hungary Italy Lebanon Lithuania Macedonia Spain United Kingdom Subgroups Anatolian Balkanian Banat Bulgarians Bessarabian Bulgarian Dobrujans Macedonian Ruptsi Balkandzhii Pomaks (Bulgarian Muslims) Thracian Shopi/Torlaks Şchei Religion Bulgarian Orthodox Church Islam Catholic Church Protestant denominations Language Bulgarian Dialects Banat Bulgarian Other List of Bulgarians People of Bulgarian descent v t e Tarator is a cold soup made of yogurt, water, minced cucumber, dill, garlic, and sunflower or olive oil (Chips are...
Anthony Warlow Warlow in Sydney in 2008 Last Phantom of the Opera performance Background information Born ( 1961-11-18 ) 18 November 1961 (age 57) Wollongong, New South Wales, Australia Genres Opera, musical theatre Occupation(s) Opera singer, actor Years active 1988–present Associated acts John Farnham, Olivia Newton John Website anthonywarlowonline.com Anthony Thorne Warlow AM (born 18 November 1961 in Wollongong, New South Wales, Australia) is an Australian opera and musical theatre performer, noted for his character acting and considerable vocal range. He is a classically trained lyric baritone. Contents 1 Performances 1.1 Musical 1.2 Opera 1.3 Gilbert and Sullivan 1.4 Other performances 2 Phantom of the Opera : 2007-2009 3 The Pirates of Penzance tour: 2006–2007 4 Awards and nominations 5 Personal life 6 Recordings 6.1 DVDs 6.2 Solo and collaborative albums 6.3 Cast albums ...